Biochemical Characterizations of the Putative Endolysin Ecd09610 Catalytic Domain from <i>Clostridioides difficile</i>

Biochemical Characterizations of the Putative Endolysin Ecd09610 Catalytic Domain from <i>Clostridioides difficile</i>

<i>Clostridioides difficile</i> is the major pathogen of pseudomembranous colitis, and novel antimicrobial agents are sought after for its treatment. Phage-derived endolysins with species-specific lytic activity have potential as novel antimicrobial agents. We surveyed the genome of <...

Full description

Bibliographic Details
Main Authors:	Hiroshi Sekiya, Hina Yamaji, Ayumi Yoshida, Risa Matsunami, Shigehiro Kamitori, Eiji Tamai
Format:	Article
Language:	English
Published:	MDPI AG 2022-08-01
Series:	Antibiotics
Subjects:	<i>Clostridioides difficile</i> endolysin antimicrobial agent antimicrobial resistance
Online Access:	https://www.mdpi.com/2079-6382/11/8/1131

Similar Items

Bacteriophage endolysins as a potential weapon to combat Clostridioides difficile infection
by: Shakhinur Islam Mondal, et al.
Published: (2020-11-01)

Assessing the Feasibility of Employing a Combination of a Bacteriophage-Derived Endolysin and Spore Germinants to Treat Relapsing <i>Clostridioides difficile</i> Infection
by: Khalid Alyahya, et al.
Published: (2023-06-01)

Evidence for an Adaptation of a Phage-Derived Holin/Endolysin System to Toxin Transport in Clostridioides difficile
by: Denise Mehner-Breitfeld, et al.
Published: (2018-10-01)

Effect of Reduced Fluoroquinolone Use on Cephalosporin Use, Susceptibilities and <i>Clostridioides difficile</i> Infections
by: Callyn Mariah Wren, et al.
Published: (2022-09-01)

<i>Clostridioides difficile</i> in Food-Producing Animals in Romania: First Study on the Prevalence and Antimicrobial Resistance
by: Corina Beres, et al.
Published: (2022-09-01)

Early Life Antimicrobial Exposure: Impact on <i>Clostridioides difficile</i> Colonization in Infants
by: Chinwe Vivien Obiakor, et al.
Published: (2022-07-01)

High Prevalence of <i>Clostridioides difficile</i> Ribotype 176 in the University Hospital in Kosice
by: Katarina Curova, et al.
Published: (2023-03-01)

Prevalence of Non-Toxigenic <i>Clostridioides difficile</i> in Diarrhoea Patients and Their Clinical Characteristics
by: Cheon-Hoo Jeon, et al.
Published: (2023-08-01)

Alimentary and Pharmaceutical Approach to Natural Antimicrobials against <i>Clostridioides difficile</i> Gastrointestinal Infection
by: Miguel Tortajada-Girbés, et al.
Published: (2021-05-01)

Gut Microbiota Composition Associated with <i>Clostridioides difficile</i> Colonization and Infection
by: Elisa Martinez, et al.
Published: (2022-07-01)

Microbiota in <i>Clostridioides difficile</i>-Associated Diarrhea: Comparison in Recurrent and Non-Recurrent Infections
by: Alessandra Gazzola, et al.
Published: (2020-09-01)

<i>Clostridioides difficile</i> as a Dynamic Vehicle for the Dissemination of Antimicrobial-Resistance Determinants: Review and In Silico Analysis
by: Philip Kartalidis, et al.
Published: (2021-06-01)

Identification of an Antimicrobial Peptide from the Venom of the Trinidad Thick-Tailed Scorpion <i>Tityus trinitatis</i> with Potent Activity against ESKAPE Pathogens and <i>Clostridioides difficile</i>
by: Milena Mechkarska, et al.
Published: (2023-09-01)

Role of the Alteration in Calcium Homeostasis in Cell Death Induced by <i>Clostridioides difficile</i> Toxin A and Toxin B
by: Katia Fettucciari, et al.
Published: (2023-08-01)

Prevalence, Antimicrobial Resistance and Toxin-Encoding Genes of <i>Clostridioides difficile</i> from Environmental Sources Contaminated by Feces
by: Khald Blau, et al.
Published: (2023-01-01)

Teicoplanin Suppresses Vegetative <i>Clostridioides difficile</i> and Spore Outgrowth
by: Suvash Chandra Ojha, et al.
Published: (2021-08-01)

A Retrospective Analysis of the Clinical Effectiveness of Tigecycline in the Treatment of <i>Clostridioides difficile</i>-Associated Diarrhea
by: Herman Joseph Johannesmeyer, et al.
Published: (2024-06-01)

Battling Enteropathogenic Clostridia: Phage Therapy for Clostridioides difficile and Clostridium perfringens
by: Jennifer Venhorst, et al.
Published: (2022-06-01)

Burden of Clostridioides difficile infection (CDI) - a systematic review of the epidemiology of primary and recurrent CDI
by: Elaine Finn, et al.
Published: (2021-05-01)

Metronidazole for Treatment of <i>Clostridioides difficile</i> Infections in Brazil: A Single-Center Experience and Risk Factors for Mortality
by: Joana Darc Freitas Alves, et al.
Published: (2022-08-01)

A New Convenient Method to Assess Antibiotic Resistance and Antimicrobial Efficacy against Pathogenic <i>Clostridioides difficile</i> Biofilms
by: Lingjun Xu, et al.
Published: (2024-08-01)

<i>Clostridioides difficile</i> Infection: Use of Inflammatory Biomarkers and Hemogram-Derived Ratios to Predict Mortality Risk in Hospitalized Patients
by: Giuseppe Guido Maria Scarlata, et al.
Published: (2024-08-01)

Updated Management Guidelines for <i>Clostridioides difficile</i> in Paediatrics
by: Margherita Gnocchi, et al.
Published: (2020-04-01)

To study the contributing factors and outcomes of Clostridioides difficile infection in patients with solid tumors
by: Kamal Kant Sahu, et al.
Published: (2021-12-01)

Characterization of Endolysin LyJH307 with Antimicrobial Activity against <i>Streptococcus bovis</i>
by: Hanbeen Kim, et al.
Published: (2020-06-01)

An Update on <i>Clostridioides difficile</i> Binary Toxin
by: Adrián Martínez-Meléndez, et al.
Published: (2022-04-01)

Phage therapy for Clostridioides difficile infection
by: Kosuke Fujimoto, et al.
Published: (2022-10-01)

Application of Microbiome Management in Therapy for <i>Clostridioides difficile</i> Infections: From Fecal Microbiota Transplantation to Probiotics to Microbiota-Preserving Antimicrobial Agents
by: Chun-Wei Chiu, et al.
Published: (2021-05-01)

Characterization of <i>Clostridioides difficile</i> Persister Cells and Their Role in Antibiotic Tolerance
by: Osvaldo Inostroza, et al.
Published: (2024-07-01)

Diversity, Dynamics and Therapeutic Application of <i>Clostridioides difficile</i> Bacteriophages
by: Janet Y. Nale, et al.
Published: (2022-12-01)

Potential Role of the Host-Derived Cell-Wall Binding Domain of Endolysin CD16/50L as a Molecular Anchor in Preservation of Uninfected Clostridioides difficile for New Rounds of Phage Infection
by: Wichuda Phothichaisri, et al.
Published: (2022-04-01)

The Incidence of <i>Clostridioides difficile</i> Infection in the Post-COVID-19 Era in a Hospital in Northern Greece
by: Maria Terzaki, et al.
Published: (2024-08-01)

<i>Clostridioides difficile</i> Infection Treatment and Outcome Disparities in a National Sample of United States Hospitals
by: Eric H. Young, et al.
Published: (2022-09-01)

An Endolysin LysSE24 by Bacteriophage LPSE1 Confers Specific Bactericidal Activity against Multidrug-Resistant <i>Salmonella</i> Strains
by: Yifeng Ding, et al.
Published: (2020-05-01)

The long and sinuous road to phage-based therapy of Clostridioides difficile infections
by: Andrew A. Umansky, et al.
Published: (2023-08-01)

<i>Clostridioides difficile</i> Infections in Children: What Is the Optimal Laboratory Diagnostic Method?
by: Mohammed Suleiman, et al.
Published: (2024-08-01)

Genomic Analysis of <i>Clostridioides difficile</i> Recovered from Horses in Western Australia
by: Natasza M. R. Hain-Saunders, et al.
Published: (2023-07-01)

The Environment, Farm Animals and Foods as Sources of <i>Clostridioides difficile</i> Infection in Humans
by: Declan Bolton, et al.
Published: (2023-03-01)

Trends in and Risk Factors for Recurrent Clostridioides difficile Infection, New Haven County, Connecticut, USA, 2015–2020
by: Chinenye M. Okafor, et al.
Published: (2023-05-01)

Prevalence of <i>Clostridioides difficile</i> Infection in Critically Ill Patients with Extreme Leukocytosis and Diarrhea
by: Bijan Teja, et al.
Published: (2021-01-01)